|
π
|
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.
17 auth.
E. Zamagni,
F. Patriarca,
C. Nanni,
B. Zannetti,
E. Englaro,
A. Pezzi,
P. Tacchetti,
S. Buttignol,
G. Perrone,
A. Brioli,
...
L. Pantani,
C. Terragna,
F. Carobolante,
M. Baccarani,
R. Fanin,
S. Fanti,
M. Cavo
|
8 |
2011 |
8
π
|
|
π
|
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
15 auth.
M. Cavo,
E. Zamagni,
P. Tosi,
P. Tacchetti,
C. Cellini,
D. Cangini,
A. de Vivo,
N. Testoni,
Chiara Nicci,
C. Terragna,
...
T. Grafone,
G. Perrone,
M. Ceccolini,
S. Tura,
M. Baccarani
|
8 |
2005 |
8
π
|
|
π
|
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.
18 auth.
E. Zamagni,
C. Nanni,
F. Patriarca,
E. Englaro,
P. Castellucci,
O. Geatti,
P. Tosi,
P. Tacchetti,
D. Cangini,
G. Perrone,
...
M. Ceccolini,
A. Brioli,
S. Buttignol,
R. Fanin,
E. Salizzoni,
M. Baccarani,
S. Fanti,
M. Cavo
|
8 |
2007 |
8
π
|
|
π
|
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma.
30 auth.
M. Cavo,
L. Pantani,
M. Petrucci,
F. Patriarca,
E. Zamagni,
D. Donnarumma,
C. Crippa,
M. Boccadoro,
G. Perrone,
A. Falcone,
C. Nozzoli,
R. Zambello,
L. Masini,
A. Furlan,
A. Brioli,
...
D. Derudas,
S. Ballanti,
M. Dessanti,
V. De Stefano,
A. Carella,
M. Marcatti,
A. Nozza,
F. Ferrara,
V. Callea,
C. Califano,
A. Pezzi,
A. Baraldi,
M. Grasso,
P. Musto,
A. Palumbo
|
8 |
2012 |
8
π
|
|
π
|
A novel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma.
20 auth.
G. GΓΆrgΓΌn,
E. Calabrese,
T. Hideshima,
J. Ecsedy,
G. Perrone,
M. Mani,
H. Ikeda,
G. Bianchi,
Yiguo Hu,
D. Cirstea,
...
L. Santo,
Y. Tai,
Sabikun Nahar,
Mei Zheng,
Madhavi Bandi,
Ruben D Carrasco,
N. Raje,
N. Munshi,
P. Richardson,
K. Anderson
|
8 |
2009 |
8
π
|
|
π
|
Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.
17 auth.
G. GΓΆrgΓΌn,
E. Calabrese,
E. Soydan,
T. Hideshima,
G. Perrone,
Madhavi Bandi,
D. Cirstea,
L. Santo,
Yiguo Hu,
Y. Tai,
...
Sabikun Nahar,
N. Mimura,
C. Fabre,
N. Raje,
N. Munshi,
P. Richardson,
K. Anderson
|
7 |
2009 |
7
π
|
|
π
|
The Monoclonal Antibody nBT062 Conjugated to Cytotoxic Maytansinoids Has Selective Cytotoxicity Against CD138-Positive Multiple Myeloma Cells In vitro and In vivo
21 auth.
H. Ikeda,
T. Hideshima,
M. Fulciniti,
R. Lutz,
H. Yasui,
Y. Okawa,
T. Kiziltepe,
S. Vallet,
S. Pozzi,
L. Santo,
...
G. Perrone,
Y. Tai,
D. Cirstea,
N. Raje,
C. Uherek,
B. DaΜlken,
S. Aigner,
F. Osterroth,
N. Munshi,
P. Richardson,
K. Anderson
|
7 |
2009 |
7
π
|
|
π
|
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
20 auth.
H. Ikeda,
T. Hideshima,
M. Fulciniti,
G. Perrone,
N. Miura,
H. Yasui,
Y. Okawa,
T. Kiziltepe,
L. Santo,
S. Vallet,
...
D. Cristea,
E. Calabrese,
G. Gorgun,
N. Raje,
P. Richardson,
N. Munshi,
B. Lannutti,
K. Puri,
N. Giese,
K. Anderson
|
7 |
2010 |
7
π
|
|
π
|
Dual Inhibition of Akt/Mammalian Target of Rapamycin Pathway by Nanoparticle Albumin-BoundβRapamycin and Perifosine Induces Antitumor Activity in Multiple Myeloma
18 auth.
D. Cirstea,
T. Hideshima,
S. Rodig,
L. Santo,
S. Pozzi,
S. Vallet,
H. Ikeda,
G. Perrone,
G. Gorgun,
K. Patel,
...
N. Desai,
P. Sportelli,
S. Kapoor,
S. Vali,
S. Mukherjee,
N. Munshi,
K. Anderson,
N. Raje
|
7 |
2010 |
7
π
|
|
π
|
AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3Ξ² activation and RNA polymerase II inhibition
19 auth.
L. Santo,
S. Vallet,
T. Hideshima,
D. Cirstea,
Hiroshi Ikeda,
Samantha Pozzi,
K. Patel,
Y. Okawa,
G. Gorgun,
G. Perrone,
...
E. Calabrese,
Murray Yule,
M. Squires,
M. Ladetto,
M. Boccadoro,
P. Richardson,
Nikhil C. Munshi,
K. C. Anderson,
N. Raje
|
6 |
2010 |
6
π
|
|
π
|
Neurological toxicity of longβterm (>1βyr) thalidomide therapy in patients with multiple myeloma
11 auth.
P. Tosi,
E. Zamagni,
C. Cellini,
R. Plasmati,
D. Cangini,
P. Tacchetti,
...
G. Perrone,
F. Pastorelli,
S. Tura,
M. Baccarani,
M. Cavo
|
6 |
2005 |
6
π
|
